Orexigen Therapeutics Inc (NASDAQ:OREX)

6.67
Delayed Data
As of May 01
 +0.10 / +1.52%
Today’s Change
3.11
Today|||52-Week Range
9.37
+10.07%
Year-to-Date

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Orexigen Therapeutics Inc have a median target of 12.00, with a high estimate of 26.00 and a low estimate of 9.00. The median estimate represents a +79.91% increase from the last price of 6.67.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Orexigen Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.16
Sales
$4.5M
Reporting Date
May 06

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly --
 
 
 
 
 
 
Growthannually -108.03%
 
 
 
 
 
 

Sales

Growthquarterly -80.29%
 
 
 
 
 
 
Growthannually -36.21%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account